Ignite Creation Date:
2025-12-24 @ 6:27 PM
Ignite Modification Date:
2026-03-04 @ 11:10 PM
Study NCT ID:
NCT03124368
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
2017-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-12
First Submit QC Date:
None
Study First Post Date:
2017-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-21
Results First Submit QC Date:
None
Results First Post Date:
2021-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-11-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-07
Last Update Post Date:
2021-11-04
Last Update Post Date Type:
ACTUAL